首页> 外文期刊>Organic process research & development >The Use of Glycidyl Ethers Involving Aziridinium Intermediates and Other Methodology for the Preparation of Enantiomerically Pure Drug Candidates
【24h】

The Use of Glycidyl Ethers Involving Aziridinium Intermediates and Other Methodology for the Preparation of Enantiomerically Pure Drug Candidates

机译:涉及氮丙啶鎓中间体的缩水甘油醚和其他方法在制备对映体纯药物候选物中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

An enantiospecific 1,2-amine migration process through an aziridinium intermediate involving ring-opening with potassium phthalimide derivatives to produce precursors to drug candidates was developed. The precursor amine derivatives were readily available by epoxide opening of simple glycidyl ether derivatives. The regioselectivity of the process was shown to provide approximately 85% of the desired rearranged product with subsequent conversion to the desired drug candidate occurring with excellent purity. An alternative approach using the same glycidyl ether derivatives as starting materials that overcame this regiochemical limitation was subsequently demonstrated.
机译:开发了一种对映体特异性的1,2-胺通过叠氮基中间体的迁移过程,该过程涉及用邻苯二甲酰亚胺钾衍生物进行开环以产生候选药物的前体。前体胺衍生物可通过简单的缩水甘油醚衍生物的环氧化物打开而容易地获得。结果表明,该方法的区域选择性提供了约85%的所需的重排产物,并随后以优异的纯度转化为所需的候选药物。随后展示了使用相同的缩水甘油醚衍生物作为起始原料的另一种方法,该方法克服了这种区域化学限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号